Skip to content
December 22, 2020

Chemi Nutra Granted New Patent For Phosphatidic Acid’s (PA) Ability To Increase Muscle Mass And Strength

Austin, TX – It is well known that an increase in mechanical loading, via resistance exercise for example, can induce muscle hypertrophy, as mechanical loads activate the human body’s signaling mechanism known as the mechanistic target of rapamycin (mTOR). In addition, it has been shown that phosphatidic acid (PA) significantly enhances mTOR signaling, when accompanied with resistance exercise, via upregulation and sustaining of muscle protein synthesis (MPS), which is directly responsible for converting amino acids into new skeletal muscle.

Following extensive investigation into the role of PA, Chemi Nutra discovered how PA could significantly influence load-induced growth of skeletal muscle by acting on the mTOR pathway. In addition, it was discovered that when taken orally, PA exhibited noticeable effects on muscle mass and strength gains, especially when adequate amounts of protein were administered within the anabolic window of individuals engaged in resistance exercise bouts.

As a result of these discoveries, Chemi Nutra proudly announces it has been granted a patent for its novel PA (United States Patent 10,869,843), with claims that it’s branded Mediator® PA, when consumed orally, and in the absence of creatine, can increase muscle mass and strength when accompanied with resistance exercise. This patent and its claims apply exclusively to Chemi Nutra’s specially compounded, branded, PA ingredient compound called Mediator® 50P Phosphatidic Acid (PA), and do not apply to other PA, or generic PA.

If any other PA or generic PA is used in a nutritional supplement where claims are made for muscle and/or strength gains, this will constitute patent infringement. And Chemi Nutra will work vigorously with no holds barred actions to defend its patent position, as intellectual property is considered a critically valuable asset. Chemi Nutra’s customers will be granted royalty free use of this patent, which further supports the incredible muscle and strength benefits of Mediator® Phosphatidic Acid (PA).

Scott Hagerman, president of Chemi Nutra said, “Mediator® Phosphatidic Acid (PA) is the “Original PA”, the only PA clinically evaluated for efficacy and safety, and the only PA proven to benefit. And now it is supported by an impressive U.S. patent.

As a company engaged in the discovery and commercial development of specialty phospholipid compounds that offer unique health and performance benefits, PA caught our attention several years ago, as we set out to prove our branded PA can accelerate muscle mass and strength gains, and fat mass loss. We have since invested considerable time and money to fully commercialize our novel, performance benefiting specialty compound, Mediator® PA, currently used as a keynote ingredient in many top level sports nutritionals for muscle mass and strength gain, fat mass loss, and muscle preservation.

The science behind PA is current and is very exciting, and PA is supported by much impressive and emerging science, demonstrating its incredible ability to accelerate muscle mass and strength gains faster than through the age-old, time tested way of working out in the gym for months and years in the pursuit of significant muscle and strength gains.

With Mediator® PA, men and woman now have a patented, all-natural, and clinically proven nutrient, that can really help speed up muscle and strength development, and can also help preserve precious, hard-earned muscle. PA is naturally found in very small concentrations in muscle, however, only in miniscule amounts due to limited presence in foods and limited biosynthesis in the body. So orally ingested Mediator® PA, as shown by human clinical studies and as claimed in this new patent, is truly exciting, and consumers now have a scientifically validated ingredient that can really impact muscle and strength like no other nutrient.”

Chemi Nutra is the U.S. business unit of parent company Chemi S.p.A., a privately held nutraceutical and pharmaceutical company based in Milan, Italy, with business and manufacturing operations located in countries around the world. Chemi, with its own U.S. FDA inspected, cGMP certified manufacturing facilities, is best known in the global nutritional arena for its commercial development and introduction of SerinAid® PhosphatidylSerine (PS), AlphaSize® Alpha-Glyceryl Phosphoryl Choline (A-GPC), Mediator® Phosphatidic Acid (PA), and IronAid® Iron Protein Succinylate (IPS). These are all widely used, patented, research validated, health, performance, and wellness benefiting dietary supplement ingredient compounds, produced by Chemi in their own company plants. This tagline is our true company storyline: We create nutrients®.

Download Content

Please complete this short form to download.


Request a Resource for Your Business

After completing a short form, our team will contact you about the product you're formulating to send the correct sample or resource.